Health Finance Coalition

What Health Finance Coalition does

Health Finance Coalition, operating under the brand BillionScale Health, is a Washington, D.C.-based coalition-building and blended finance organization that identifies, finances, and scales breakthrough health interventions to reach one billion people each within a decade. The organization operates a platform-plus-portfolio model that brings together funders, innovators, and local partners to deploy catalytic capital into health solutions targeting the highest-burden countries in Asia, Africa, and Latin America. Its stated approach is a "capital stack" methodology that aims to convert every $1 of catalytic grant capital into $10 of country commitments, concessional loans, consumer spending, and commercial investment.

The organization's core portfolio comprises four named deals: (1) Spatial Repellents, a mosquito-borne disease prevention technology deployed in enclosed spaces as a lower-cost alternative to insecticide-treated bed nets; (2) Wolbachia, a nature-based mosquito control intervention intended to protect up to one billion people from dengue and other vector-borne diseases; (3) the Transform Health Fund, a $109.9 million blended finance vehicle directed at health innovation for vulnerable populations; and (4) the ExCITD Platform, a partnership with the Asian Development Bank to unlock billions in country-based scale-up financing for health innovations across Asia-Pacific. The organization explicitly cites a track record of "billion-scaling the bed net" as prior proof of concept.

Business model mechanics are philanthropic and grant-based rather than commercial: the organization mobilizes catalytic capital, structures blended finance vehicles, and brokers partnerships rather than selling a product or licensing technology directly. Revenue and employee headcount (1-10) are not publicly disclosed, and no parent company, institutional investors, or traditional equity funding rounds are documented. GTM is coalition-driven, relying on relationships with multilateral institutions (notably ADB), funders, and country-level public health stakeholders.

Name

Health Finance Coalition

Website

https://healthfinancecoalition.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Health Finance Coalition (BillionScale Health) is a Washington, D.C.-based blended finance organization that mobilizes catalytic capital and coalition partnerships to scale breakthrough health interventions—such as spatial repellents, Wolbachia, and the $109.9M Transform Health Fund—across high-burden countries in Asia, Africa, and Latin America.

Ownership category

akta.pro rank

Product category

Global Health Financing and Blended Finance Services

NAICS

Voluntary Health Organizations (813212), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Global Health Financing Mechanisms & Pooled Funds (HLAJAOAC)

akta.pro secondary industries

Global Health Financing Mechanisms (HLAJAKAC), Healthcare Access & Life Sciences Impact Funds (FSANAJAI), Public Health Financing, Budgeting & Grants Management (HLAJAMAC)

Keywords

• Blended finance structuring
• Global health scaling
• Catalytic capital deployment
• Public health coalition
• Health innovation financing

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Core offering

Health Finance Coalition (operating as BillionScale Health) is a mission-driven coalition that identifies breakthrough health solutions and structures blended finance deals to scale them to one billion people in high-burden countries across Asia, Africa, and Latin America. Its core deliverable is a portfolio of investible deals (e.g., Spatial Repellents, Wolbachia, the $109.9 million Transform Health Fund, and the ADB ExCITD platform) financed through a capital-stack approach that multiplies catalytic grant capital tenfold via country commitments, concessional loans, and commercial investment.

Product overview

BillionScale Health operates as a mission-driven financing and scaling organization that identifies and invests in breakthrough health solutions. The organization functions as a platform-plus-portfolio model, bringing together funders, innovators, and local partners to scale health interventions. Its core offerings include four major health investments: Spatial Repellents (mosquito control technology), Wolbachia (nature-based mosquito solution), the Transform Health Fund ($109.9 million blended finance vehicle), and the ExCITD Platform (in partnership with Asian Development Bank for Asia-Pacific health innovation scaling). The organization takes a 'capital stack' approach that turns every $1 in catalytic grant capital into $10 in country commitments, concessional loans, consumer spending, and commercial investment.

Differentiator

Problem solved

Functional benefit

Products and services

• Spatial Repellents Deal A scaled health-financing deal that deploys spatial repellent technology as a protective barrier against mosquitoes inside homes, classrooms, and other enclosed spaces to prevent mosquito-borne diseases, targeted at populations in high-burden countries.
• Wolbachia Scaling Deal A scaling deal that deploys Wolbachia bacteria as a nature-based mosquito control solution intended to protect up to 1 billion people from dengue and other mosquito-borne diseases, particularly in high-burden Asian, African, and Latin American countries.
• Transform Health Fund A $109.9 million blended finance fund that brings health innovation, quality, and access to vulnerable populations, structured to channel catalytic grant capital together with country commitments, concessional loans, consumer spending, and commercial investment.
• ExCITD Platform (with Asian Development Bank) A partnership-led platform with the Asian Development Bank that unlocks billions of dollars to support country-based scale-up of health innovations across immunization and communicable disease control in the Asia-Pacific region.

Quantifiable outcome

• Turns every $1 in catalytic grant capital into $10 in country commitments, concessional loans, consumer spending and commercial investment

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Asian Development Bank (ADB)coreStrategic or Co-development PartnerAsian Development Bank is unlocking billions of dollars to support country-based scale-up of innovations in the Asia-Pacific region through the ExCITD platform.
• Funders, innovators and local partnerscoreOthersBillionScale Health brings together funders, innovators and local partners to achieve scale in high-burden countries.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Wellcome Trust: A large UK-based foundation funding a wide portfolio of health research and intervention scale-up globally. A broader incumbent in the health grantmaking space with comparable ambition to fund breakthrough health solutions at scale.

Direct peers

• MedAccess: A UK-based social enterprise that uses volume guarantees and other innovative finance tools to accelerate access to medical products in LMICs. Closely comparable on blended finance structuring for global health product scale-up.
• PATH: A global health nonprofit that develops, introduces, and scales health innovations including vaccines, devices, and diagnostics in LMICs. Comparable in taking targeted health solutions from proof-of-concept to national-scale deployment.
• Gavi, the Vaccine Alliance: A public-private partnership that mobilizes catalytic and market-shaping capital to scale immunization in the world's poorest countries. Comparable coalition model, country-level deployment, and donor/government co-financing structure.
• Clinton Health Access Initiative (CHAI): An operating NGO that negotiates pricing, supplies, and financing arrangements to expand access to essential medicines and diagnostics in low- and middle-income countries. Shares the explicit mission of scaling health access through deal-making with funders, governments, and suppliers.
• Unitaid: A hosted partnership that invests in innovative health technologies and access models for HIV, tuberculosis, malaria, and related diseases. Comparable focus on identifying breakthrough interventions and scaling them through innovative financing.
• The Global Fund to Fight AIDS, Tuberculosis and Malaria: A multilateral financing institution that pools donor contributions and channels them to country-led programs for major infectious diseases. Overlaps strongly on mission, funding architecture, and country-level partnership model in the same geographies.
• Global Financing Facility for Women, Children and Adolescents: A multi-stakeholder global health financing platform that pools catalytic and concessional capital to scale country-led health interventions. Directly comparable in mandate and blended-finance mechanisms for health access in low- and middle-income countries.

Emerging players

• Convergence Blended Finance: A global network that curates and supports blended finance transactions across sectors, including health. Comparable on innovative financing architecture and mobilizing catalytic capital for development outcomes.
• Financing Alliance for Health: An Africa-focused organization that helps governments design and finance primary healthcare and community health systems. Comparable on structuring blended and government co-financed health deals in target geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/health-finance-coalition

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Finance Coalition